Item 9 Labs Corp (INLB)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 02, 16:00
Item 9 Labs Gross Profit (TTM): 9.805M for June 30, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 9.805M |
March 31, 2023 | 8.576M |
December 31, 2022 | 7.535M |
September 30, 2022 | 7.312M |
June 30, 2022 | 7.967M |
March 31, 2022 | 9.268M |
December 31, 2021 | 9.580M |
September 30, 2021 | 8.613M |
June 30, 2021 | 8.513M |
March 31, 2021 | 6.641M |
December 31, 2020 | 4.246M |
September 30, 2020 | 3.300M |
June 30, 2020 | 2.551M |
March 31, 2020 | 2.377M |
December 31, 2019 | 2.384M |
September 30, 2019 | 2.378M |
June 30, 2019 | 2.023M |
March 31, 2019 | 1.242M |
December 31, 2018 | 0.7199M |
September 30, 2018 | 0.3025M |
June 30, 2018 | 0.251M |
March 31, 2018 | 0.2788M |
December 31, 2017 | 0.2198M |
September 30, 2017 | 0.1632M |
Date | Value |
---|---|
June 30, 2017 | 0.2173M |
March 31, 2017 | 0.139M |
December 31, 2016 | 0.1225M |
September 30, 2016 | 0.1657M |
June 30, 2016 | 0.0234M |
March 31, 2016 | 0.0092M |
December 31, 2015 | 0.0079M |
September 30, 2015 | -0.0043M |
June 30, 2015 | 0.0341M |
March 31, 2015 | 0.0911M |
December 31, 2014 | 0.0942M |
September 30, 2014 | 0.0638M |
June 30, 2014 | 0.1623M |
March 31, 2014 | 0.1041M |
December 31, 2013 | 0.1727M |
September 30, 2013 | 0.1982M |
June 30, 2013 | 0.097M |
March 31, 2013 | 0.1082M |
December 31, 2012 | 0.034M |
June 30, 2012 | 0.0024M |
March 31, 2012 | -0.0026M |
December 31, 2011 | 0.0056M |
September 30, 2011 | 0.0056M |
June 30, 2011 | 0.0056M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
2.023M
Minimum
Jun 2019
9.805M
Maximum
Jun 2023
6.063M
Average
7.312M
Median
Sep 2022
Gross Profit (TTM) Benchmarks
Cantabio Pharmaceuticals Inc | -- |
Q BioMed Inc | -0.0126M |
NVN Liquidation Inc | 16.26M |
Affymax Inc | -- |
Scopus BioPharma Inc | -- |